Sign in
CompletedNo phase

Non-Invasive Monitoring of Traumatic Brain Injury Progression Using the Infrascanner (MOBI-1)

Key facts

Who runs it
University of Alabama at Birmingham
Where
Birmingham and Tucson, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
399 people enrolled
Started
18 Apr 2022
Ended
25 Aug 2025
Type of study
Observational
Treatments tested
  • Standard care plus infrascans
Record updated
2 September 2025

Who can take part

Age
15 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age 15 or older
  • Admission CT Scan shows intracranial hemorrhage
  • Glasgow Coma Scale less than 15
  • Neurosurgery service determines initial care is nonoperative
  • Admitted for observation for TBI, to either step-down unit or intensive care unit

Who cannot take part

  • Admitted and observed for >2 hours prior to screening (i.e., has already received second neurological check)
  • Planned surgical interventions/ procedures during study period (before the second CT scan)
  • Inability to provide informed consent or lack of a legally authorized representative (LAR)
  • Other injuries deemed non-survivable
  • Diagnosed with hemorrhagic shock or receives a large volume transfusion (>3 units of any blood product within any 1 hour)
  • Known prisoner

Where in United States

  • UAB HospitalBirmingham, United States
  • University of ArizonaTucson, United States

About the trial

What the trial wants to find out

MOBI-1 is a multicenter clinical trial that will evaluate the use of the Infrascanner for the monitoring of traumatic intracranial hematomas.

The group in the trial

  • Standard care plus infrascans

    All participants will receive regular clinical neurological assessments as ordered by the clinical care team. In addition, a research team member will perform an infrascan. This process will be repeated hourly at the same timepoint as the clinical neurological assessments. If a patient's neurological status deteriorates at any time point, and the medical team orders an early (unplanned) CT scan, the neurological data collection will cease once the patient is sent to CT. Infrascan results will not be shared with the clinical care team, and will not guide the participants' care in any way.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
2 September 2025